Multidrug resistance
the majior obstacles to the successful treatment of tumors. MDR may result from structural or functional changes at the plasma membrane or within the cytoplasm, cellular compartments, or nucleus. Molecular mechanisms of MDR are discussed in terms of modifications in detoxification and DNA repair pathways, changes in cellular sites of drug sequestration, decreases in drug-target affinity, synthesis of specific drug inhibitors within cells, altered or inappropriate targeting of proteins, and accelerated removal or secretion of drugs.
A central goal in the study of chemotherapy is to understand how tumor cells can become drug resistant by lowering the intracellular concentration of antitumor agents and/or altering the ability of these drugs to affect their targets. During the past 10 years, scores of different tumor and transformed cell lines have been studied, using equally as many different types of antitumor drugs. A general theme that has emerged from these investigations is that the mechanisms of multidrug resistance (MDR) are opportunistic in their manipulation and modification of normal pathways of cellular homeostasis. This article reviews both what we know-that a variety of changes in cellular mechanisms can produce MDR-and what we do not-that is, which, if any, cellular changes actually lead to MDR. In this article emphasis is given to experimental evidence that supports a variety of mechanisms for MDR, specifically: (i) altered composition and physical interactions of plasma membrane phospholipids; (ii) enhanced drug binding and cellular accumulation; (iii) changed levels of expression and activity of plasma membrane or endomembrane channels, transporters, and translocators; (iv) altered rates of endocytosis and subsequent subcellular targeting of endosomes; (v) altered rates and extent of exocytosis; (vi) modified ionic environments, such as pH, Ca2+ concentration of the extra-, intra-, or subcellular compartments; and (vii) alterations in the activity and expression of proteins necessary for drug detoxification and DNA replication and repair systems.
Our understanding of MDR in tumor cells has been limited by our lack of knowledge of the particular properties that make these cells more sensitive than surrounding normal tissue to cytotoxic drugs. More fundamentally, it is also unclear whether MDR is the consequence of tumors' losing a hypersensitivity to drugs or of alternative mechanisms that make the cells more resistant to the drugs. It has been suggested that tumors are extra sensitive to drugs because their replication rates are higher than normal cells. This may be the basis of their increased sensitivity to drugs that affect DNA replication and the cytoskeleton of the cell, which are the primary targets of chemotherapy. An alternative but not mutually exclusive explanation is based on the observation that chemotherapeutic drugs accumulate in tumor cells to higher concentrations than in normal cells. The higher sensitivity may reflect solely the higher intracellular drug concentration.
Drug resistance may subvert the same mechanisms that make tumor cells hypersensitive. If (6, 7) and HlyB (which in Escherichia The most pri coli transports a large protein, hemol-servation in ysin) (8) (22) (23) (24) (25) (26) (27) (28) (29) , an inLux of drugs (27, 28, (30) (31) (32) (33) , ased trapping of drugs either sol (34) (35) (36) or in subcellular nts (36, 37 (36, 37, 39, 40) . Any effects on drug sequestration will affect the cyto-and nucleoplasmic concentration.
(iii) Exocytosis. Since anticancer drugs accumulate in the endocytic/exocytotic pathways, an increased rate of exocytosis (37) can result in greater trapping of drugs into sequestered transport compartments followed by expulsion of the drugs from the cell. This would decrease the drug concentration in the cytoplasm.
(iv) pH Hypothesis. Most cytotoxic drugs are weak bases with pK values between 7.4 and 8.2 (41) (42) (43) . In their neutral form, they are hydrophobic and easily traverse membranes. In their protonated form, they are membrane impermeant. The relative distribution between the neutral and charged forms is determined by the concentration of protons. The pH within tumor cells is considerably more acidic than that of normal cells (44) . This acidity results in the protonation of these molecules in the cytosol, thereby trapping them in their membrane-impermeant but biologically active form (45) . Further, it is the protonated form of these drugs that can bind to their targets such as DNA (45) (46) (47) (48) (49) (50) , RNA (49, 51) , and tubulin (52, 53) . Thus, the acid pH of tumor cells could result in drug accumulation by ionic ligation (intracellular binding) and/or ionic trapping (more acidic cytoplasm) (36) . This accumulation would favor the partitioning of drug into the nucleoplasm, leading to the cytotoxic effect. The pH of MDR cells is usually more alkaline (54, 55) than that of drug-sensitive cells, a condition that would act to reverse cellular accumulation of the drugs.
(v) Nuclear Mechanisms. Since the principal target for most presently employed chemotherapeutic agents is the DNA, it is reasonable to assume that MDR is achieved in cells by preventing drug accumulation in the nucleus and the resultant drug proximity or binding to DNA and associated nuclear proteins. Studies examining the interaction of acridines, actinomycins, and anthracyclines with DNA demonstrate that such drugs can inactivate the DNA template in transcription and replication by inducing topoisomerase-I1-mediated single-strand breaks in the DNA (13, 21, 56) . Potential nuclear targets of opportunity for the induction of MDR are through modifications in (i) mechanisms of drug translocation across the nuclear envelope/pore complex; (ii) binding sites in the DNA, RNA, nucleoli, and nuclear matrix; (iii) DNA repair mechanisms; and (iv) efficiency of mRNA export and protein import into the nucleus.
(vi) Cytoplasmic Mechanisms. There are a number ofcytosolic mechanisms for eliminating toxic reagents, including the enhanced activity of the pentose phosphate shunt (57) and changes in glutathione metabolism (58) (59) (60) . Enzymes involved in both of these pathways are modified in some MDR cell lines. A potential mechanism for drug cytotoxicity is related to the free-radical-forming ability of these drugs. Superoxide, hydrogen peroxide, and hydroxyl radicals are reactive oxygen species which can form in the reduction of oxygen by the anthracycline semiquinones. The Fe(Il)-doxorubicin complex is able to catalyze the oxidation of thiol by O2, promoting the oxidative destruction of macromolecular targets (13, 14, 16, 17, (58) (59) (60) .
(vii) Plasma Membrane Mechanisms. The plasma membrane in MDR cells appears different from that in drug-sensitive parental cells (61) . The alterations may reflect changes in specific phospholipid interactions with proteins associated with MDR. Alternatively, these differences in membrane composition and organization may be due to ionic interactions of drugs with the head groups of phospholipids which are asymmetrically distributed in either leaflet of the bilayer (62) (63) (64) . Such changes could have a significant influence on the transmembrane partitioning of the drug by a non-channel diffusion-mediated process.
Evaluation of the Models ATP-Driven Drug Efflux Pump. Shortly after the identification ofthe Pgp, it was noticed that, in the presence of azide, anticancer drugs accumulate in "drug-resistant" cell lines (32) , suggesting an ATP-driven process. This model was significantly strengthened when the Pgp was cloned and demonstrated to have two ATP-binding sites and a strong homology to a family of membrane transporters (4, 8) . Transfection of cells with Pgp is sufficient to confer an MDR phenotype-a significant observation which firmly establishes a role for Pgp in MDR (65, 66 (70) (71) (72) while also interfering with drug and inhibitor binding (73) . Plasma membrane vesicles from MDR cells overexpressing Pgp showed a higher rate of drug transport than those vesicles from drug-sensitive cells (74) .
There is considerable evidence to support the hypothesis that the Pgp functions as an ATPase to modify the cellular concentration of drugs. It remains unresolved whether it is a transport channel for the drugs. There are at least four diagnostic features used to identify an ATPase pump that remain to be demonstrated for the Pgp: (i) specificity; ( There are a number of additional problems with a drug-efflux pump. Drug influx is reduced in MDR cells (based on measurements of initial rates) (22) (23) (24) (25) (26) (27) (28) (29) (84) . There is a growing body of evidence supporting a model by which peptide or protein translocation across membranes occurs through transmembrane protein-conducting channels (85) (86) (87) . Similarly, overexpression of Pgp yields a concomitant increased chloride channel activity (88) . This raises a number ofmechanistic questions, central ofwhich is how this protein can be both an aqueous channel and a pump.
Compartmentalization /Exocytosis/pH. The compartmentalization/ exocytosis/pH models are closely intertwined. Many of the anticancer drugs are fluorescent, which has facilitated microscopic studies of their subcellular distribution. Their fluorescence is primarily punctate, an observation that is indicative of their localization to intracellular organelles-primarily Golgi and lysosomes (36, 40, 89) . Any mechanism that increases the trapping of drugs in these compartments facilitates cell survival by decreasing drug concentration in the cytosol and nucleoplasm. An increased transport of membrane vesicles from the endocytic-secretory pathway to the surface exocytoses the drugs from the cell (37) . One key mechanism that affects both trapping of these drugs in these compartments and the transport out of (103) . It is also important to note that sphingomyelin has been implicated as a cofactor in the transport of cholesterol from the Golgi to the plasma membrane (104) . Changes in the metabolism of sphingomyelin may also influence the composition of the Golgi (enhanced cholesterol concentration) and plasma membrane (cholesterol depletion).
Exocytosis. Membrane recycling is increased in MDR cells (105, 106 A number of the proteins overexpressed in MDR are members ofthe ABC family. They bear structural homology to the cystic fibrosis transmembrane regulator (CFTR) and, as with CFTR, overexpression of these proteins is correlated with an increased number ofion channels (88, (107) (108) (109) (110) . In the intestine, a switch occurs from CFTR to Pgp expression as the cells migrate across the crypt-villus boundary (111) . A switch from CFTR to Pgp expression was also observed in the uterine epithelium with the onset of pregnancy. Considering the role of CFTR as a regulator of secretory activity in epithelia (as a cAMP-controlled Cl-transport channel), it is possible to speculate that Pgp and MRP either directly or indirectly also influence secretory mechanisms leading to alterations in drug accumulation and the MDR phenotype (93) . These results lead to the prediction that pathways for the development of MDR in cells may depend on the overexpression and/or modification of a number of ATPases or ATP-binding proteins that are directly or indirectly involved in maintaining transmembrane ionic equilibria or controlling cellular mechanisms of uptake and secretion. Overexpression of membrane ATPases could lead to significant changes in both transmembrane ionic fluxes and gradients and their regulatory machinery, resulting in significant modifications in the functioning of integrated pathways of coordinated transport. Such changes would affect symport and possibly substrate specificity of membrane transport proteins.
CellularpH. This model is based on the observation that antitumor drugs are sufficiently hydrophobic to cross membranes. The asymmetric distribution of the drugs is assumed to be the consequence of an asymmetry of chemical potential (such as ApH, voltage, and ionic concentrations). For example, the higher rate of aerobic glycolysis in tumors causes an acidic environment (44) , which should have two effects on the passive distribution of drugs. First, most of the chemotherapeutic agents are weak bases. When these drugs are neutral they can freely diffuse across membranes; when protonated, they are charged and significantly less permeant. These drugs are, thus, trapped in the acidic cytosol of tumors. Second, the binding of each of these drugs to their cytosolic targets, such as tubulin (52, 53) or DNA (45) (46) (47) (48) (49) , has an acidic pH optimum. For example the cross-linking ofDNA by mitomycin C is increased at acidic pH (50) . Thus, an acidic environment simultaneously increases the amount ofdrug that is trapped inside the cells and the binding ofdrugs to their targets. Conversely, an alkaline shift ofthe pH both decreases the amount of drug inside the cell and reduces its potential for binding.
A role for pH in trapping drugs is consistent with a number of observations. In erythrocyte ghosts (91) and phospholipid vesicles (112) the transmembrane distributions of these drugs are determined by the ApH. In MDR cells the cellular pH often increases with increased drug resistance (54) . The cytosolic pH becomes alkaline in drugsensitive cells that are transfected with the Pgp (55) . Changing the cytosolic pH of drug-sensitive cells to the pH of drugresistant cells (in the absence of any MDR proteins) is sufficient to quantitatively account for the decreased drug accumulation observed in MDR (36) . The same result is observed independent of the means by which the pH is changed (ammonium chloride or C02). Verapamil, which reverses MDR, partially reverses this shift of cytosolic pH (54) . Drugs which acidify the cytosol, such as amiloride, reverse MDR (113) .
Not all observations can be reconciled with the pH hypothesis. An MDR cell line has been identified whose cellular pH does not differ from the parental drugsensitive lines (114) . It is possible that there are some subcellular changes of pH that are not detected by a total cellular measurement. Alternatively, there may be forms of MDR that do not utilize pH.
It is also necessary to explain how expression of Pgp could affect cellular pH. Cells use a variety of mechanisms to keep their pH close to neutral (115) (116) (117) . The cellular membrane potential is usually 50-80 mV (with the inside negative). Thus, if protons are allowed to equilibrate across the plasma membrane, the cytosol is significantly more acidic. The steady-state pH is a balance between proton influx (due to the electrochemical gradient), proton generation (from metabolism), and proton efflux (due to proton pumps, Na+/H+ exchangers, Cl-/ HC03-exchangers, just to name a few). Tumor cells may use any or all mechanisms at their disposal to neutralize their pH and evade the chemotherapeutic agents. Depolarization of cells has been demonstrated to lead to alkalization of a number of different cell types (118) (119) (120) . Overexpression of the Pgp in NIH 3T3 fibroblasts reveals a chloride conductance (88) . Activation of this channel would depolarize the cell if the Nernst potential for chloride is more positive than the membrane potential. An immediate effect would be to decrease the driving force for proton entry into cells. However, depolanization has also been shown to cause an alkaline shift by modulating Na+-lactate/H+-lactate exchange (119, 120) and Na+/HCO3 cotransport (121) . Consistent with this hypothesis, experimental results using voltagesensitive dyes suggest that the membrane potentials in drug-resistant cells are different from those in drug-sensitive cells (122, 123) .
Nuclear Mechanisms. Since the principal target for most presently employed chemotherapeutic agents is the DNA and/or associated proteins, it is reasonable to assume that MDR can be conferred on cells by the prevention of drug accumulation in the nucleus or the desensitization of nuclear components to the drugs. An example of such altered drug sensitivity may be represented by the altered expression and/or activity of topoisomerase 11 (13, 16, 19, 21 (125, 126) . However, this form of drug presentation may not be physiologically relevant (127, 128 (57) . There was unaltered hexokinase activity, higher glucose-6-phosphate dehydrogenase activity, increased glutathione, and marked increase of glutathione peroxidase activity after cell exposure to an oxidizing agent (57) . Other experiments demonstrate correlations between enhanced Pgp expression and that of glutathione S-transferase ir, thymidylate synthase, and metallothionein, suggesting multiple resistance mechanisms (14) . In related studies, an MCF-7 human breast carcinoma cell line was selected for resistance to vincristine (59) . Addition of a nontoxic concentration of verapamil significantly enhances vincristine-induced cytotoxicity. This resistance is associated with the overexpression of Pgp but without a concomitant increase in Pgp mRNA or gene amplification. Increased activity of cellular protein kinase C has been implicated in this increased activity of Pgp (129) . Activities oftotal glutathione S-transferases (GSTs) and glutathione peroxidase are also elevated with overexpression of the GST-ir isozyme and its associated mRNA. The data suggest a role for modifications in glutathione metabolism in MDR. Other more recent studies suggest a limited correlation between Pgpmediated MDR and GST expression or activity (14) .
Plasma Membrane Mechanisms. A decrease of drug influx has been observed in many MDR cell lines (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . Since most antitumor drugs can freely cross pure lipid bilayers, it is difficult to explain the decreased influx without postulating a change ofmembrane structure. Freezefracture studies reveal increases in the densities of protoplasmic face intramembrane particles in MDR Chinese hamster ovary (CHO) and human leukemic cells (61) . This is not observed in revertants, suggesting that MDR may be associated with changes in plasma membrane architecture. Examinations of the effect of lipids and detergents on the ATPase activity of Pgp indicate a well-defined lipid preference for saturated phosphatidylethanolamine and fluid lipid mixtures (130) . Treatment of cells with different detergents has also modified the accumulation and cytotoxicity of antitumor drugs (29, 131, 132) . In a direct investigation of the interaction of daunomycin with the plasma membranes from tumor cells, it was found that drug binding is directly related to the availability of anionic phospholipid head groups (133) . Previous studies of cell cytotoxicity with immobilized adriamycin show that the interaction of the drug with the plasma membrane is sufficient to kill cells (125) (126) (127) (128) (135) . There is strong evidence that interleukin 1 (136) and thioredoxin (137) are transported directly across the plasma membrane. They do not have a signal sequence and are not glycosylated, and blocking the secretory pathway with brefeldin A does not affect their export. Identification ofthe normal physiological ligands may suggest new strategies for reversing MDR and facilitate mechanistic studies on the transport properties of these proteins. This would then help resolve such issues as whether the Pgp is a drug-efflux pump, a transmembrane aqueous pore through which drugs diffuse, or a modifier of the transmembrane environment which only indirectly affects drug transport.
A third challenge is to devise new strategies for analyzing MDR that can relate the phenomenology of in vitro studies with clinically observed drug resistance. There are a number ofproblems associated with our current approaches. First, much effort is expended on developing cell lines that show greater and greater degrees of resistance to chemotherapy. This is based on the beliefthat it will be easier to study the mechanisms by overexpressing the responsible agents. Cells grown in vitro are exposed to everhigher concentrations of antitumor drugs. However, resistant cells in situ are usually not more than 5-to 10-fold resistant. Indeed, such cells would never be exposed to higher concentrations because of drug cytotoxicity. The results described in this review indicate that many cell biological mechanisms can be subverted to enable a cell to escape from chemotherapy. Rather than focus on the mechanisms that can make an in vitro MDR line 100-or 1000-fold more resistant than normal cells, it may be more informative to delineate the mechanisms that make tumor cells hypersensitive and determine how that enhanced sensitivity is lost as a result of MDR. The principal challenge is to identify those mechanisms that are used by tumors in situ to acquire the characteristics of clinical MDR.
It is also important to note that many of these tumors grow as masses-not as isolated cells in a tissue culture dish. These masses present a completely different series of problems for chemotherapy (138, 139) and are relatively drug resistant. This is, in part, due to poor vascularization in the tumor, which reduces the influx of antitumor drugs, and a hypoxic acidic environment, which lowers growth rates. 02 concentrations in tissue culture can approach 190-220 pM (140) . Most normal tissues demonstrate an in vivo range from 25 to 50 AM. In tumor masses, 02 can decline to 5 puM throughout the tumor. The pH within tumor masses can range down to 5.8-6.4 (140) . The 
